Skip to main content
BAK
NYSE Industrial Applications And Services

Braskem 3Q26 Recurring EBITDA Collapses to US$382M From US$1,043M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
7
Price
$1.14
Mkt Cap
$478.972M
52W Low
$0.743
52W High
$5.395
52W Position info
54% above low
Off High info
79% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

BAK sits 54% above its 52-week low of $0.743 on light trading volume (0.2× avg).

Summary

Braskem's 3Q26 recurring EBITDA dropped to US$382 million from US$1,043 million in 2Q26 as spreads normalized, and the margin fell to 9.5%. Cash generation of US$416 million and a shrinking Alagoas provision are the few positives as the company works through its restructuring.


Key Events · Earnings and Guidance · BAK

  • Recurring EBITDA Falls 63% Sequentially

    Consolidated recurring EBITDA came in at US$382 million in 3Q26, down from US$1,043 million in 2Q26, as petrochemical spreads normalized after the 2Q26 peak. The EBITDA margin fell to 9.5% from 24.2%.

  • Brazil Segment Hit Hardest

    Brazil/South America recurring EBITDA fell to US$267 million, 69% below 2Q26, on normalization of international resin and main-chemical spreads. USA & Europe contributed US$489 million and Mexico US$57 million.

  • Cash Generation of US$416 Million

    Recurring cash generated in 3Q26 was US$416 million, driven by a positive working capital change from higher commercial credit limits and inventory optimization, partly offset by US$151 million of capex.

  • Alagoas Provision Largely Disbursed

    The Alagoas provision totals R$18.2 billion, of which R$16.0 billion has been paid and R$1.2 billion reclassified to other payables. The net provision balance fell to R$3.195 billion at September 30, 2026 from R$3.247 billion at June 30.


Analysis · BAK · Industrial Applications And Services

The core problem underneath Braskem's out-of-court restructuring is now plain: the business is generating far less cash just as it needs to service and renegotiate R$187.07 billion of debt. Recurring EBITDA fell to US$382 million in 3Q26 from US$1,043 million in 2Q26 as petrochemical spreads normalized after the 2Q26 cyclical peak — a 63% sequential drop that leaves the EBITDA margin at 9.5% versus 24.2%. Liquidity is the one offset, with recurring cash generation of US$416 million in the quarter helped by working capital. The Alagoas provision is also largely paid down: R$16.0 billion of the R$18.2 billion has been disbursed, and the net balance is down to R$3.195 billion. Management's own outlook has benchmark spreads staying below the 2016-2025 average through 2027, so there is no near-term earnings recovery to lean on while the restructuring plays out.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BAK was trading at $1.14 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $479M. The 52-week trading range was $0.74 to $5.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BAK - Latest Insights

BAK
Nov 12, 2026, 8:13 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.13
Real-time Price: $1.14 info
Change: +$0.0050 (+0.44%) info
Market Cap: $478.972M info
BAK
Nov 12, 2026, 7:18 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.14 info
Change: +$0.0749 (+7%) info
Market Cap: $478.972M info
BAK
Nov 10, 2026, 8:27 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $1.14 info
Change: +$0.035 (+3%) info
Market Cap: $478.972M info
BAK
Nov 06, 2026, 7:58 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $1.14 info
Change: +$0.045 (+4%) info
Market Cap: $478.972M info
BAK
Oct 29, 2026, 8:19 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $1.14 info
Change: +$0.025 (+2%) info
Market Cap: $478.972M info